Skip to Content
Merck
  • Using Serologic Testing to Assess the Effectiveness of Outbreak Control Efforts, Serial Polymerase Chain Reaction Testing, and Cohorting of Positive Severe Acute Respiratory Syndrome Coronavirus 2 Patients in a Skilled Nursing Facility.

Using Serologic Testing to Assess the Effectiveness of Outbreak Control Efforts, Serial Polymerase Chain Reaction Testing, and Cohorting of Positive Severe Acute Respiratory Syndrome Coronavirus 2 Patients in a Skilled Nursing Facility.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2020-08-29)
Amy V Dora, Alexander Winnett, Jennifer A Fulcher, Linda Sohn, Feliza Calub, Ian Lee-Chang, Elham Ghadishah, William A Schwartzman, David O Beenhouwer, John Vallone, Christopher J Graber, Matthew Bidwell Goetz, Debika Bhattacharya
ABSTRACT

We characterized serology following a nursing home outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) where residents were serially tested by reverse-transcription polymerase chain reaction (RT-PCR) and positive residents were cohorted. When tested 46-76 days later, 24 of 26 RT-PCR-positive residents were seropositive; none of the 124 RT-PCR-negative residents had confirmed seropositivity, supporting serial SARS-CoV-2 RT-PCR testing and cohorting in nursing homes.

MATERIALS
Product Number
Brand
Product Description

Supelco
4-Aminoantipyrine, for spectrophotometric det. of H2O2 and phenols, ≥98.0%